Skip to main content
. 2024 Nov 29;14(12):9419–9430. doi: 10.21037/qims-24-1017

Figure 2.

Figure 2

The ROC curves for predicting csPCa in young patients with suspected disease of PI-RADS, PSAD, and an integrated model incorporating PI-RADS, PSAD, and chief complaint. ROC, receiver operating characteristic; csPCa, clinically significant prostate cancer; PI-RADS, Prostate Imaging Reporting and Data System; PSAD, prostate-specific antigen density.